Discontinued — last reported Q4 '25
Long-term investments
Non-Current AssetsEli Lilly Long-term investments decreased by 0.2% to $2.80B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.9%, from $3.22B to $2.80B. Over 5 years (FY 2020 to FY 2025), Long-term investments shows relatively stable performance with a -1.1% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ2 2009
Last reportedQ4 2025
How to read this metric
Reflects long-term capital deployment and strategic partnerships; value fluctuations can impact net income depending on accounting methods.
Detailed definition
Assets such as debt securities, equity in other companies, or other financial instruments intended to be held for more t...
Peer comparison
Common in cash-rich tech companies that take minority stakes in emerging startups or AI ventures.
Metric ID:
long_term_investmentsHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.47B | $3.35B | $3.21B | $2.73B | $2.59B | $2.57B | $2.90B | $2.75B | $2.75B | $2.69B | $3.05B | $3.09B | $2.88B | $3.20B | $3.22B | $3.22B | $3.21B | $2.81B | $2.80B |
| QoQ Change | — | -3.6% | -4.1% | -15.1% | -5.1% | -0.5% | +12.7% | -5.2% | -0.2% | -1.9% | +13.4% | +1.1% | -6.8% | +11.2% | +0.5% | +0.2% | -0.5% | -12.4% | -0.2% |
| YoY Change | — | — | — | — | -25.5% | -23.2% | -9.7% | +0.8% | +6.1% | +4.5% | +5.2% | +12.2% | +4.8% | +18.9% | +5.4% | +4.4% | +11.5% | -12.2% | -12.9% |
Range$2.57B – $3.47B
CAGR-4.7%
Avg YoY Growth-0.6%
Median YoY Growth+4.5%
Current Streak3 quarters decline
Long-term investments at Other Companies
Frequently Asked Questions
- What is Eli Lilly's long-term investments?
- Eli Lilly (LLY) reported long-term investments of $2.80B in Q4 2025.
- How has Eli Lilly's long-term investments changed year-over-year?
- Eli Lilly's long-term investments decreased by 12.9% year-over-year, from $3.22B to $2.80B.
- What is the long-term trend for Eli Lilly's long-term investments?
- Over 5 years (2020 to 2025), Eli Lilly's long-term investments has grown at a -1.1% compound annual growth rate (CAGR), from $2.97B to $2.80B.
- What does long-term investments mean?
- Investments the company plans to keep for a long time, usually more than a year.